<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18735" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Butterbur</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Din</surname>
            <given-names>Lennox</given-names>
          </name>
          <aff>California Northstate University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lui</surname>
            <given-names>Forshing</given-names>
          </name>
          <aff>CA Northstate Uni, College of Med</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Lennox Din declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Forshing Lui declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18735.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Butterbur (derived from the leaves of Petasites hybridus) is an herbal supplement that has been found to be effective in the prophylaxis of adult migraines in multiple studies. Based on these trials, the American Headache Society gave the herb a level A recommendation and declared it effective in preventing migraine headaches. This activity reviews the mechanism of action, adverse event profile, toxicity, dosing, and pharmacodynamics of butterbur and the recommended monitoring of patients taking the drug to avoid adverse effects.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the proposed mechanism of action of butterbur in relieving migraine headaches.</p></list-item><list-item><p>Review the indications for initiating butterbur.</p></list-item><list-item><p>Summarize the contraindications of butterbur.</p></list-item><list-item><p>Discuss interprofessional team strategies for improving care coordination and communication when considering or using butterbur in migraine management.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18735&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18735">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18735.s2" sec-type="Indications">
        <title>Indications</title>
        <p>
<bold>FDA Approved Indications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>None</p>
          </list-item>
        </list>
        <p>
<bold>Non-FDA Approved Indications</bold>
</p>
        <p>
<bold>Adult Migraine</bold>
</p>
        <p>The American Headache Society and the American Academy of Neurology: 2012 evidence-based&#x000a0;guideline update indicated that Petasites (butterbur) demonstrates effectiveness for migraine prevention and is a valid option for patients with migraine to reduce both the severity and frequency of migraine attacks (Level A). The recommendation was questioned and then retracted in 2016.<xref ref-type="bibr" rid="article-18735.r1">[1]</xref></p>
        <p>Butterbur (leaves of Petasites <italic toggle="yes">hybridus</italic>) has been&#x000a0;found&#x000a0;to be&#x000a0;effective in the prophylaxis of adult migraines in multiple studies.<xref ref-type="bibr" rid="article-18735.r2">[2]</xref> Based on these trials, the American Headache Society gave the herb a level A recommendation and declared it to be effective in the prevention of migraine headaches. Similarly, the Canadian Headache Society guidelines give butterbur a strong recommendation for use in&#x000a0;migraine prophylaxis.<xref ref-type="bibr" rid="article-18735.r3">[3]</xref> Although the American Academy of Neurology recommended butterbur, it has retracted its current guidelines on it.<xref ref-type="bibr" rid="article-18735.r3">[3]</xref> In the United Kingdom and Germany, butterbur&#x000a0;is not authorized for official use due to safety concerns.<xref ref-type="bibr" rid="article-18735.r3">[3]</xref> In one randomized, parallel-group study from 2004, the group given butterbur had a response rate of 45%, whereas the group who used placebo had a response rate of 15%. In another randomized controlled trial from 2004, butterbur reduced the frequency of migraines by 48% in the experimental group, whereas the placebo reduced the frequency by 26% in the control group.<xref ref-type="bibr" rid="article-18735.r2">[2]</xref></p>
        <p>
<bold>Pediatric Migraine</bold>
</p>
        <p>Similar to adult migraines, there is evidence for&#x000a0;Petasites in the prevention of pediatric migraines.<xref ref-type="bibr" rid="article-18735.r4">[4]</xref> In one randomized controlled trial from 2005, butterbur reduced the frequency of attacks by at least 50% in 77% of the pediatric experimental group.<xref ref-type="bibr" rid="article-18735.r2">[2]</xref>&#x000a0;In another randomized controlled trial from 2008, butterbur reduced the frequency of attacks by 59% in the experimental group, whereas the placebo reduced the frequency of attacks by 31% in the control group.<xref ref-type="bibr" rid="article-18735.r5">[5]</xref>&#x000a0;</p>
        <p>
<bold>Allergic Rhinitis and Asthma</bold>
</p>
        <p>Butterbur has been used in countries in Asia as a herbal treatment of asthma and allergic diseases.<xref ref-type="bibr" rid="article-18735.r6">[6]</xref>There is a limited body of evidence from randomized controlled trials that butterbur may be useful as a therapy for asthma and allergic rhinitis but not as effective as preventing migraine.<xref ref-type="bibr" rid="article-18735.r2">[2]</xref><xref ref-type="bibr" rid="article-18735.r7">[7]</xref></p>
        <p>
<bold>Alzheimer's Disease</bold>
</p>
        <p>Studies have found that butterbur may potentially be effective in treating Alzheimer's disease due to its neuroprotective effect. However, only studies involving in vitro and in vivo models have been performed.<xref ref-type="bibr" rid="article-18735.r8">[8]</xref></p>
      </sec>
      <sec id="article-18735.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>
<bold>Mechanism of Action for the Treatment of Migraines</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Petasites inhibit the opening of L-type voltage-gated calcium channels, decreasing vasoconstriction of vessels and excitation of neurons.<xref ref-type="bibr" rid="article-18735.r4">[4]</xref> The herb's active components include Sesquiterpenes (Petasin and Isopetasin) which have&#x000a0;been found to exhibit anti-inflammatory effects through the inhibition of COX-2. This leads to decreased leukotriene synthesis and prostaglandin E2 release.<xref ref-type="bibr" rid="article-18735.r9">[9]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Mechanism of Action for the Treatment of Asthma and Allergic Rhinitis</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Petatewalide B, a derivative of Petasites, has also been found to exhibit anti-allergic activities.<xref ref-type="bibr" rid="article-18735.r6">[6]</xref> Specifically, the compound inhibits the activation of &#x000df;-hexosaminidase in RBL-2H3 mast cells. Petatewalide B also inhibits nitric oxide synthase, which decreases nitric oxide production in mouse peritoneal macrophages. The compound also decreases the concentration of eosinophils, macrophages, and lymphocytes in mouse bronchoalveolar lavage fluid.<xref ref-type="bibr" rid="article-18735.r6">[6]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Mechanism of Action for the Treatment of Alzheimer Disease</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Derivatives of Petasites have been found to have antioxidant activity; the DPPH free radical-scavenging value and ferric ion reducing potential were both increased.<xref ref-type="bibr" rid="article-18735.r10">[10]</xref> In one study examining the cognitive effects of butterbur, the herb significantly decreased levels of reactive oxygen species (ROS) levels and increased the viability of HT22 mouse neuronal cells exposed to A&#x000df; plaques. The study found that the mechanism for the former was related to increased expression of heme oxygenase-1 (HO-1), NAD(P)H quinine dehydrogenase 1, and cyclic AMP response element-binding protein (CREB), which are all involved in antioxidant pathways.<xref ref-type="bibr" rid="article-18735.r8">[8]</xref> Similarly, in A&#x000df; plaque-injected mice, the administration of butterbur resulted in significantly decreased CREB expression in the dentate gyrus.<xref ref-type="bibr" rid="article-18735.r8">[8]</xref>&#x000a0;&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18735.s4" sec-type="Administration">
        <title>Administration</title>
        <p>Butterbur is given almost exclusively via oral administration.<xref ref-type="bibr" rid="article-18735.r11">[11]</xref>&#x000a0;The recommended daily dose is between 50 mg to 150 mg.</p>
      </sec>
      <sec id="article-18735.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>Previous randomized controlled trials have found no serious adverse effects and good overall tolerance of the drug.<xref ref-type="bibr" rid="article-18735.r2">[2]</xref> Minor effects include gastrointestinal symptoms (belching is the most common), dyspepsia, headache, itchy eyes, drowsiness, fatigue, and asthma. Long-term use of butterbur may rarely lead to cholestatic hepatitis (estimated incidence of 1:175,000). Patients who are&#x000a0;allergic to ragweed and daisies may also have similar allergic reactions to butterbur.<xref ref-type="bibr" rid="article-18735.r2">[2]</xref></p>
        <p>One major area of concern regarding safety is with pyrrolizidine alkaloids which are commonly found in the butterbur plant.<xref ref-type="bibr" rid="article-18735.r9">[9]</xref> These substances can cause hepatotoxicity, lung toxicity, carcinogenesis, and thrombosis. Fortunately, the commercial preparation process of butterbur typically removes these substances. Thus, it is recommended for consumers of butterbur only buy brands that are&#x000a0;free of alkaloids and other plant carcinogens.</p>
        <p>Severe hepatotoxicity may be&#x000a0;associated with butterbur use, but the evidence is unclear. From the World Health Organization's Vigibase, one study reported 40 cases of hepatotoxicity, including two liver transplants associated with the use of Petasites formulations.<xref ref-type="bibr" rid="article-18735.r3">[3]</xref> However, these cases may be the result&#x000a0;of the use of butterbur contaminated with alkaloids. Another article reported detecting levels of toxic alkaloids in seven out of 21 commercially available compounds.<xref ref-type="bibr" rid="article-18735.r3">[3]</xref> Therefore, at least some brands are inadequately removing alkaloids from their butterbur formulations. In summary, it is unclear if hepatotoxicity is due to alkaloids in the formulation or the butterbur itself. To evaluate the hepatotoxic effects of butterbur more clearly, a future study can collect data on brands that claim to be alkaloid-free by thoroughly reviewing the literature and the Periodic Update Safety Report. The data can then be analyzed with the Roussel Uclaf Causality Assessment Method test to determine if butterbur carries an association with hepatotoxicity.<xref ref-type="bibr" rid="article-18735.r12">[12]</xref></p>
      </sec>
      <sec id="article-18735.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Butterbur use is contraindicated in patients using anticholinergic medications. Also, there have not been studies establishing safety criteria in children under six or pregnant or lactating women. Therefore, butterbur use is not recommended in these groups.<xref ref-type="bibr" rid="article-18735.r9">[9]</xref></p>
      </sec>
      <sec id="article-18735.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>Multiple studies recommend a daily dose of 50-150 mg.<xref ref-type="bibr" rid="article-18735.r11">[11]</xref> Monitoring liver function (AST, ALT,&#x000a0; ALP, GCT, bilirubin) is recommended due to potential hepatotoxicity from butterbur or drug contamination with&#x000a0;pyrrolizidine alkaloids.<xref ref-type="bibr" rid="article-18735.r2">[2]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-18735.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>The list of side effects of butterbur is in the adverse effects section. Long-term use of butterbur may rarely lead to reversible cholestatic hepatitis (estimated incidence of 1:175,000).<xref ref-type="bibr" rid="article-18735.r9">[9]</xref> Butterbur may also interact with anticholinergic medications. There is no known antidote for butterbur overdose. The recommendation in such cases is to cease using the drug.</p>
      </sec>
      <sec id="article-18735.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>There have been no formal studies examining interprofessional care and its relationship to butterbur. Nevertheless,&#x000a0;close&#x000a0;coordination&#x000a0;among all interprofessional healthcare team members, including clinicians (MDs, DOs, PAs, NPs), nurses, pharmacists, and other healthcare providers, is recommended to monitor for side effects and interactions with other medications, especially anticholinergics. As a herbal remedy, butterbur may often not appear on a patient's official prescribed medication list. Therefore, every healthcare provider needs to inquire about alternative or natural remedies when interviewing patients and record it in the patient's chart. By employing interprofessional care coordination and open communication, the healthcare team can optimize patient care and prevent adverse events for patients using butterbur. [Level 5]</p>
      </sec>
      <sec id="article-18735.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18735&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18735">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18735/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18735">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18735.s11">
        <title>References</title>
        <ref id="article-18735.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holland</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Silberstein</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Freitag</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dodick</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Argoff</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ashman</surname>
                <given-names>E</given-names>
              </name>
              <collab>Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society</collab>
            </person-group>
            <article-title>Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.</article-title>
            <source>Neurology</source>
            <year>2012</year>
            <month>Apr</month>
            <day>24</day>
            <volume>78</volume>
            <issue>17</issue>
            <fpage>1346</fpage>
            <page-range>1346-53</page-range>
            <pub-id pub-id-type="pmid">22529203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18735.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The evidence for herbal and botanical remedies, Part 1.</article-title>
            <source>J Fam Pract</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-16</page-range>
            <pub-id pub-id-type="pmid">29309469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18735.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajapakse</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pringsheim</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Nutraceuticals in Migraine: A Summary of Existing Guidelines for Use.</article-title>
            <source>Headache</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>56</volume>
            <issue>4</issue>
            <fpage>808</fpage>
            <page-range>808-16</page-range>
            <pub-id pub-id-type="pmid">26954394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18735.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orr</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>The Evidence for the Role of Nutraceuticals in the Management of Pediatric Migraine: a Review.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2018</year>
            <month>Apr</month>
            <day>04</day>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>37</fpage>
            <pub-id pub-id-type="pmid">29619575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18735.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oelkers-Ax</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Leins</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parzer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hillecke</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bolay</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bender</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hermanns</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Resch</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study.</article-title>
            <source>Eur J Pain</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>301</fpage>
            <page-range>301-13</page-range>
            <pub-id pub-id-type="pmid">17659990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18735.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YG</given-names>
              </name>
              <name>
                <surname>Im</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Petatewalide B, a novel compound from Petasites japonicus with anti-allergic activity.</article-title>
            <source>J Ethnopharmacol</source>
            <year>2016</year>
            <month>Feb</month>
            <day>03</day>
            <volume>178</volume>
            <fpage>17</fpage>
            <page-range>17-24</page-range>
            <pub-id pub-id-type="pmid">26674157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18735.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Haggart</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Robb</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Lipworth</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Butterbur, a herbal remedy, confers complementary anti-inflammatory activity in asthmatic patients receiving inhaled corticosteroids.</article-title>
            <source>Clin Exp Allergy</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>110</fpage>
            <page-range>110-4</page-range>
            <pub-id pub-id-type="pmid">14720270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18735.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Butterbur Leaves Attenuate Memory Impairment and Neuronal Cell Damage in Amyloid Beta-Induced Alzheimer's Disease Models.</article-title>
            <source>Int J Mol Sci</source>
            <year>2018</year>
            <month>Jun</month>
            <day>01</day>
            <volume>19</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">29865187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18735.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Andrea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cevoli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cologno</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Herbal therapy in migraine.</article-title>
            <source>Neurol Sci</source>
            <year>2014</year>
            <month>May</month>
            <volume>35 Suppl 1</volume>
            <fpage>135</fpage>
            <page-range>135-40</page-range>
            <pub-id pub-id-type="pmid">24867850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18735.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ezzatzadeh</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hossaini</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Green synthesis and antioxidant activity of novel series of benzofurans from euparin extracted of <italic>Petasites hybridus</italic>.</article-title>
            <source>Nat Prod Res</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>11</issue>
            <fpage>1617</fpage>
            <page-range>1617-1623</page-range>
            <pub-id pub-id-type="pmid">29376428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18735.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Onofrio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Raimo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Spitaleri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Casucci</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bussone</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Usefulness of nutraceuticals in migraine prophylaxis.</article-title>
            <source>Neurol Sci</source>
            <year>2017</year>
            <month>May</month>
            <volume>38</volume>
            <issue>Suppl 1</issue>
            <fpage>117</fpage>
            <page-range>117-120</page-range>
            <pub-id pub-id-type="pmid">28527067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18735.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>[Carefully reviewing the history of diagnostic scales and paying more attention to the diagnostic value of Roussel - Uclaf causality assessment method scale for drug - induced liver injury].</article-title>
            <source>Zhonghua Gan Zang Bing Za Zhi</source>
            <year>2016</year>
            <month>Nov</month>
            <day>20</day>
            <volume>24</volume>
            <issue>11</issue>
            <fpage>801</fpage>
            <page-range>801-803</page-range>
            <pub-id pub-id-type="pmid">27978922</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
